Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases including multiple sclerosis, pediatric leukodystrophies, traumatic injury and age-related pathologies such as Alzheimer’s. Convelo has identified key biological targets and a pipeline of drug candidates to provide novel and meaningful solutions for patients and their families.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 11000 Cedar Ave, Cleveland,ohio 44106,united States
- Phone
- 216-658-3969
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- convelotx.com
- HQ
- Cleveland, Ohio
Convelo Therapeutics, Inc Questions
Convelo Therapeutics, Inc's helpline number is 216-658-3969
Convelo Therapeutics, Inc's website is convelotx.com
Convelo Therapeutics, Inc's LinkedIn profile is https://www.linkedin.com/company/convelotx
Convelo Therapeutics, Inc has
8 employees.
View email and phone details for 8
employees at Convelo Therapeutics, Inc.
Convelo Therapeutics, Inc's industry is
Biotechnology Research
Convelo Therapeutics, Inc's top competitors are
Copernicus Therapeutics, Inc.,
Diasome Pharmaceuticals, Inc.,
Allinaire Therapeutics,
Kurome Therapeutics, Inc.,
Analiza,
Andelyn Biosciences,
Haima Therapeutics,
Clarametyx Biosciences,
Abeona Therapeutics,
Athersys.
Convelo Therapeutics, Inc's categories are Biotechnology Research
Convelo Therapeutics, Inc's founding year is 2016
